Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_assertion type Assertion NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_head.
- NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_assertion description "[In the latter group, the stimulatory KIR2DS5 gene was associated with improved leukemia free survival (p=0.007; hazard ratio 4.3; 95% confidence interval 1.3-6.7) and lower relapse rates (p=0.028; HR 4.3, 95% CI 1.1-9.1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_provenance.
- NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_assertion evidence source_evidence_literature NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_provenance.
- NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_assertion SIO_000772 18555529 NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_provenance.
- NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_assertion wasDerivedFrom befree-20140225 NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_provenance.
- NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_assertion wasGeneratedBy ECO_0000203 NP769542.RAgqY1XCgvt2XeYU8syOpVNdl0KYxfBzTXZzZfpZGdsD4130_provenance.